M D Basson1, L Panzini, R H Palmer. 1. Wayne State University Medical School, Detroit, MI, USA. marc.basson@med.ua.gov
Abstract
BACKGROUND: The management of patients taking aspirin or non-steroidal anti-inflammatory drugs (NSAIDs) who require colonoscopy remains controversial because of concerns over bleeding after biopsy or polypectomy. AIM: To determine whether patients using the NSAID nabumetone, a non-acidic prodrug with mixed activity against cyclooxygenase-1 (COX-1) and COX-2, exhibited prolonged mucosal bleeding times and how this might compare with mucosal bleeding times in patients using aspirin. METHODS: We assessed triplicate mucosal bleeding times in patients undergoing screening flexible sigmoidoscopy. We compared 90 patients who had taken no aspirin or NSAIDs within the previous 2 weeks, to 60 patients who had received nabumetone 1 g b.d. by mouth for the previous 2 weeks, and 30 patients who had taken 325 mgaspirin daily for the previous 2 weeks. In each case, the investigator performing the study was blinded to the patient's medication. RESULTS:Mucosal bleeding times did not differ significantly among control or nabumetone-using patients. However, the patients receiving aspirin exhibited significant prolongation. Mucosal bleeding time correlated statistically significantly, but weakly, with skin bleeding time. CONCLUSIONS: Nabumetone does not appear to prolong mucosal bleeding time after mucosal pinch biopsy, and skin bleeding time does not reliably screen for prolonged mucosal bleeding time.
RCT Entities:
BACKGROUND: The management of patients taking aspirin or non-steroidal anti-inflammatory drugs (NSAIDs) who require colonoscopy remains controversial because of concerns over bleeding after biopsy or polypectomy. AIM: To determine whether patients using the NSAID nabumetone, a non-acidic prodrug with mixed activity against cyclooxygenase-1 (COX-1) and COX-2, exhibited prolonged mucosal bleeding times and how this might compare with mucosal bleeding times in patients using aspirin. METHODS: We assessed triplicate mucosal bleeding times in patients undergoing screening flexible sigmoidoscopy. We compared 90 patients who had taken no aspirin or NSAIDs within the previous 2 weeks, to 60 patients who had received nabumetone 1 g b.d. by mouth for the previous 2 weeks, and 30 patients who had taken 325 mg aspirin daily for the previous 2 weeks. In each case, the investigator performing the study was blinded to the patient's medication. RESULTS:Mucosal bleeding times did not differ significantly among control or nabumetone-using patients. However, the patients receiving aspirin exhibited significant prolongation. Mucosal bleeding time correlated statistically significantly, but weakly, with skin bleeding time. CONCLUSIONS:Nabumetone does not appear to prolong mucosal bleeding time after mucosal pinch biopsy, and skin bleeding time does not reliably screen for prolonged mucosal bleeding time.
Authors: Linda A Feagins; Fatema S Uddin; Raquel E Davila; William V Harford; Stuart J Spechler Journal: Dig Dis Sci Date: 2011-04-01 Impact factor: 3.199
Authors: Michael H Pillinger; Victoria Dinsell; Beth Apsel; Sonia N Tolani; Nada Marjanovic; Edwin S L Chan; Paul Gomez; Robert Clancy; Lih-Fan Chang; Steven B Abramson Journal: Br J Pharmacol Date: 2004-06-21 Impact factor: 8.739
Authors: Vijay Kanakadandi; Sravanthi Parasa; Preetika Sihn; Mandeep Singh; Maria Giacchino; Neil Gupta; Srinivas Gaddam; Amit Rastogi; Ajay Bansal; John Petrini; Prateek Sharma Journal: Endosc Int Open Date: 2015-06-24
Authors: Shara Ket; Andrew Metz; Alan Moss; Ravinder Ogra; William Tam; Robyn Secomb; John Reynolds; Peter R Gibson; Gregor Brown Journal: Contemp Clin Trials Commun Date: 2019-11-01